Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−23 JPY
−763.75 M JPY
269.49 M JPY
21.06 M
About STELLA PHARMA CORPORATION
Sector
Industry
Headquarters
Osaka
Website
Founded
2007
ISIN
JP3399680002
FIGI
BBG00ZR25CY9
Stella Pharma Corp. engages in the development, manufacture, and sale of pharmaceuticals. It provides boron-based drugs used for Boron Neutron Capture Therapy (BNCT), a form of radiotherapy that targets cancer cells using biochemical methods. The company was founded on June 1, 2007 and is headquartered in Osaka, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4888 is 537 JPY — it has decreased by −3.07% in the past 24 hours. Watch STELLA PHARMA CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange STELLA PHARMA CORPORATION stocks are traded under the ticker 4888.
4888 stock has fallen by −1.83% compared to the previous week, the month change is a 8.27% rise, over the last year STELLA PHARMA CORPORATION has showed a 90.43% increase.
4888 reached its all-time high on Jan 4, 2022 with the price of 1,070 JPY, and its all-time low was 229 JPY and was reached on Feb 15, 2024. View more price dynamics on 4888 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4888 stock is 3.75% volatile and has beta coefficient of 0.88. Track STELLA PHARMA CORPORATION stock price on the chart and check out the list of the most volatile stocks — is STELLA PHARMA CORPORATION there?
Today STELLA PHARMA CORPORATION has the market capitalization of 18.85 B, it has decreased by −1.80% over the last week.
Yes, you can track STELLA PHARMA CORPORATION financials in yearly and quarterly reports right on TradingView.
STELLA PHARMA CORPORATION is going to release the next earnings report on Feb 7, 2025. Keep track of upcoming events with our Earnings Calendar.
4888 net income for the last quarter is −106.96 M JPY, while the quarter before that showed −161.76 M JPY of net income which accounts for 33.88% change. Track more STELLA PHARMA CORPORATION financial stats to get the full picture.
No, 4888 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 44.00 employees. See our rating of the largest employees — is STELLA PHARMA CORPORATION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. STELLA PHARMA CORPORATION EBITDA is −692.76 M JPY, and current EBITDA margin is −269.12%. See more stats in STELLA PHARMA CORPORATION financial statements.
Like other stocks, 4888 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade STELLA PHARMA CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So STELLA PHARMA CORPORATION technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating STELLA PHARMA CORPORATION stock shows the buy signal. See more of STELLA PHARMA CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.